Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Chem Biol Drug Des. 2012 Jan 30;79(4):376–383. doi: 10.1111/j.1747-0285.2011.01295.x

Table 3.

Structures and binding affinities of synthesized compounds

Compound R1 R2 R3 KD’ (μM)a
J01-007 -ph-4-CH3 -ph-3-F -i-Bu 2.27
J01-012 -ph-4-CH3 -ph-3-CN -i-Bu 1.83
J01-015 -ph-4-CH3 -ph-5-CH3 -i-Bu 2.96
J02-001 -ph -ph-3-F -i-Bu 7.67
J02-002 -ph -ph-4-F -i-Bu 3.49
J01-017a -ph-4-CH3 -ph-3,4-2F-5-CH3 -i-Bu ____b
a

KD values obtained directly by NMR titration (12).

b

KD could not be obtained by NMR titration due to slow exchange.

HHS Vulnerability Disclosure